| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 5.16e-07 | 4 | 102 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.86e-06 | 18 | 102 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.56e-06 | 6 | 102 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.82e-05 | 31 | 102 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.34e-05 | 33 | 102 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 2.56e-04 | 5 | 102 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | ubiquitin ligase complex scaffold activity | 3.82e-04 | 6 | 102 | 2 | GO:0160072 | |
| GeneOntologyMolecularFunction | RISC complex binding | 3.82e-04 | 6 | 102 | 2 | GO:1905172 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.71e-04 | 193 | 102 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 5.25e-04 | 197 | 102 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 5.34e-04 | 7 | 102 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB2 POLR1A OBSCN POLRMT NME2P1 FGFRL1 ADCK2 GUCY2C PIK3CB NRK PKN2 TAF1 EPHA7 | 9.71e-04 | 938 | 102 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | protein kinase activity | 9.93e-04 | 600 | 102 | 10 | GO:0004672 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.17e-03 | 230 | 102 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | kinase activity | EPHB2 OBSCN NME2P1 FGFRL1 ADCK2 GUCY2C PIK3CB NRK PKN2 TAF1 EPHA7 | 1.80e-03 | 764 | 102 | 11 | GO:0016301 |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.86e-03 | 102 | 102 | 4 | GO:0016410 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.94e-03 | 13 | 102 | 2 | GO:0008046 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 2.26e-03 | 51 | 102 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | CUL4A CUL3 GATAD2A ANK2 RRP1B POU2AF1 XPC KAT2B SND1 CARD9 MED26 KAT6B STX17 MPP7 | 2.28e-03 | 1160 | 102 | 14 | GO:0030674 |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 2.60e-03 | 15 | 102 | 2 | GO:0005005 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.60e-03 | 15 | 102 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | glucosidase activity | 2.60e-03 | 15 | 102 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.80e-03 | 55 | 102 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 3.37e-03 | 709 | 102 | 10 | GO:0016773 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 3.59e-03 | 60 | 102 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 4.17e-03 | 19 | 102 | 2 | GO:0005003 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.34e-03 | 129 | 102 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 4.49e-03 | 65 | 102 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 4.63e-03 | 303 | 102 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | calcium ion binding | 4.96e-03 | 749 | 102 | 10 | GO:0005509 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 5.22e-07 | 14 | 101 | 4 | GO:0071415 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 1.03e-05 | 153 | 101 | 7 | GO:0051208 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.06e-05 | 359 | 101 | 10 | GO:0006874 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 1.83e-05 | 11 | 101 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by trans-synaptic complex | 1.83e-05 | 11 | 101 | 3 | GO:0099545 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 2.12e-05 | 389 | 101 | 10 | GO:0055074 | |
| GeneOntologyBiologicalProcess | protein localization to M-band | 2.37e-05 | 2 | 101 | 2 | GO:0036309 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 3.16e-05 | 37 | 101 | 4 | GO:0014808 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | EPHB2 CUL3 ARHGAP10 OBSCN ARHGEF12 PLEKHG5 TGM2 PIK3CB MAPRE2 | 3.80e-05 | 333 | 101 | 9 | GO:0051056 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 3.90e-05 | 39 | 101 | 4 | GO:1903514 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 4.32e-05 | 40 | 101 | 4 | GO:0071312 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 6.32e-05 | 44 | 101 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | maltose metabolic process | 7.10e-05 | 3 | 101 | 2 | GO:0000023 | |
| GeneOntologyBiologicalProcess | regulation of SA node cell action potential | 7.10e-05 | 3 | 101 | 2 | GO:0098907 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 8.28e-05 | 146 | 101 | 6 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 8.59e-05 | 147 | 101 | 6 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 9.26e-05 | 149 | 101 | 6 | GO:0051282 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell action potential | 1.42e-04 | 4 | 101 | 2 | GO:0098910 | |
| GeneOntologyBiologicalProcess | cellular response to ATP | 1.42e-04 | 21 | 101 | 3 | GO:0071318 | |
| GeneOntologyBiologicalProcess | response to caffeine | 1.42e-04 | 21 | 101 | 3 | GO:0031000 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | ATP7B ANK2 MYO5A TRPM2 NUBP1 RYR1 RYR2 RYR3 TGM2 PIK3CB CCR1 | 2.01e-04 | 611 | 101 | 11 | GO:0030003 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | ATP7B ANK2 MYO5A TRPM2 NUBP1 RYR1 RYR2 RYR3 TGM2 PIK3CB CCR1 | 2.34e-04 | 622 | 101 | 11 | GO:0098771 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | ATP7B ANK2 MYO5A TRPM2 NUBP1 RYR1 RYR2 RYR3 TGM2 PIK3CB CCR1 | 2.34e-04 | 622 | 101 | 11 | GO:0006873 |
| GeneOntologyBiologicalProcess | retrograde trans-synaptic signaling by trans-synaptic protein complex | 2.35e-04 | 5 | 101 | 2 | GO:0098942 | |
| GeneOntologyBiologicalProcess | regulation of AV node cell action potential | 2.35e-04 | 5 | 101 | 2 | GO:0098904 | |
| GeneOntologyBiologicalProcess | negative regulation of cytosolic calcium ion concentration | 2.42e-04 | 25 | 101 | 3 | GO:0051481 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 2.86e-04 | 259 | 101 | 7 | GO:0051651 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | EPHB2 CUL3 ARHGAP10 OBSCN ARHGEF12 PLEKHG5 TGM2 PIK3CB FARP1 MAPRE2 | 3.08e-04 | 538 | 101 | 10 | GO:0007264 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 3.36e-04 | 266 | 101 | 7 | GO:0019722 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | ATP7B ANK2 MYO5A TRPM2 NUBP1 RYR1 RYR2 RYR3 TGM2 PIK3CB CCR1 | 6.70e-04 | 705 | 101 | 11 | GO:0055080 |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 2.93e-06 | 46 | 102 | 5 | GO:0005790 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 5.71e-05 | 137 | 102 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | A band | 1.21e-04 | 52 | 102 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.36e-04 | 230 | 102 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | I band | 1.64e-04 | 166 | 102 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | junctional membrane complex | 8.30e-04 | 9 | 102 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | Z disc | 8.73e-04 | 151 | 102 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 1.03e-03 | 10 | 102 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.38e-03 | 45 | 102 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | sarcomere | 1.40e-03 | 249 | 102 | 6 | GO:0030017 | |
| Domain | Ryanodine_rcpt | 1.53e-07 | 3 | 101 | 3 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.53e-07 | 3 | 101 | 3 | IPR009460 | |
| Domain | RyR | 1.53e-07 | 3 | 101 | 3 | PF02026 | |
| Domain | RR_TM4-6 | 1.53e-07 | 3 | 101 | 3 | PF06459 | |
| Domain | Ryan_recept | 1.53e-07 | 3 | 101 | 3 | IPR013333 | |
| Domain | RIH_assoc-dom | 3.03e-06 | 6 | 101 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 3.03e-06 | 6 | 101 | 3 | PF08709 | |
| Domain | RIH_assoc | 3.03e-06 | 6 | 101 | 3 | PF08454 | |
| Domain | RIH_dom | 3.03e-06 | 6 | 101 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.03e-06 | 6 | 101 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.03e-06 | 6 | 101 | 3 | IPR015925 | |
| Domain | - | 3.03e-06 | 6 | 101 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 3.03e-06 | 6 | 101 | 3 | PF01365 | |
| Domain | MIR | 1.79e-05 | 10 | 101 | 3 | PF02815 | |
| Domain | MIR_motif | 1.79e-05 | 10 | 101 | 3 | IPR016093 | |
| Domain | MIR | 1.79e-05 | 10 | 101 | 3 | PS50919 | |
| Domain | MIR | 1.79e-05 | 10 | 101 | 3 | SM00472 | |
| Domain | S-AdoMet_decarboxylase | 2.90e-05 | 2 | 101 | 2 | IPR001985 | |
| Domain | DH_1 | 3.76e-04 | 63 | 101 | 4 | PS00741 | |
| Domain | Glyco_hydro_31_AS | 4.28e-04 | 6 | 101 | 2 | IPR030458 | |
| Domain | RhoGEF | 5.03e-04 | 68 | 101 | 4 | SM00325 | |
| Domain | RhoGEF | 5.62e-04 | 70 | 101 | 4 | PF00621 | |
| Domain | DH_2 | 5.62e-04 | 70 | 101 | 4 | PS50010 | |
| Domain | - | 5.93e-04 | 71 | 101 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 5.93e-04 | 71 | 101 | 4 | IPR000219 | |
| Domain | Glyco_hydro_31 | 5.97e-04 | 7 | 101 | 2 | IPR000322 | |
| Domain | Cullin_CS | 5.97e-04 | 7 | 101 | 2 | IPR016157 | |
| Domain | Glyco_hydro_31 | 5.97e-04 | 7 | 101 | 2 | PF01055 | |
| Domain | CULLIN | 5.97e-04 | 7 | 101 | 2 | SM00182 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 5.97e-04 | 7 | 101 | 2 | PS00129 | |
| Domain | Cullin_neddylation_domain | 7.94e-04 | 8 | 101 | 2 | IPR019559 | |
| Domain | Cullin_Nedd8 | 7.94e-04 | 8 | 101 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 7.94e-04 | 8 | 101 | 2 | SM00884 | |
| Domain | Cullin_homology | 1.02e-03 | 9 | 101 | 2 | IPR016158 | |
| Domain | GDS_CDC24_CS | 1.22e-03 | 39 | 101 | 3 | IPR001331 | |
| Domain | - | 1.22e-03 | 39 | 101 | 3 | 2.120.10.30 | |
| Domain | Cullin | 1.27e-03 | 10 | 101 | 2 | PF00888 | |
| Domain | CULLIN_2 | 1.27e-03 | 10 | 101 | 2 | PS50069 | |
| Domain | Cullin_N | 1.27e-03 | 10 | 101 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 1.27e-03 | 10 | 101 | 2 | PS01256 | |
| Domain | Ephrin_rec_like | 1.54e-03 | 11 | 101 | 2 | PF07699 | |
| Domain | Cullin_repeat-like_dom | 1.84e-03 | 12 | 101 | 2 | IPR016159 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.97e-03 | 46 | 101 | 3 | IPR011042 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 2.53e-03 | 14 | 101 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 2.53e-03 | 14 | 101 | 2 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 2.53e-03 | 14 | 101 | 2 | IPR001426 | |
| Domain | EphA2_TM | 2.53e-03 | 14 | 101 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 2.53e-03 | 14 | 101 | 2 | IPR001090 | |
| Domain | Eph_TM | 2.53e-03 | 14 | 101 | 2 | IPR027936 | |
| Domain | EPH_lbd | 2.53e-03 | 14 | 101 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 2.53e-03 | 14 | 101 | 2 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 2.53e-03 | 14 | 101 | 2 | IPR016257 | |
| Domain | EPH_LBD | 2.53e-03 | 14 | 101 | 2 | PS51550 | |
| Domain | EGF_2 | 3.18e-03 | 265 | 101 | 6 | PS01186 | |
| Domain | Ion_trans_dom | 3.41e-03 | 114 | 101 | 4 | IPR005821 | |
| Domain | Ion_trans | 3.41e-03 | 114 | 101 | 4 | PF00520 | |
| Domain | Gal_mutarotase_SF_dom | 3.73e-03 | 17 | 101 | 2 | IPR011013 | |
| Domain | Chromodomain_CS | 4.19e-03 | 18 | 101 | 2 | IPR023779 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.81e-05 | 11 | 80 | 3 | M47958 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 4.83e-05 | 13 | 80 | 3 | M39589 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.53e-04 | 142 | 80 | 6 | MM15576 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.60e-04 | 19 | 80 | 3 | M47760 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.99e-04 | 149 | 80 | 6 | M41805 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | C11orf98 POLR1A GATAD2A MYO5A ACLY SMCHD1 MATR3 POLRMT CHD1 XPC SMARCAD1 PGD CSDE1 TGM2 MFAP1 GTF2I SND1 PKN2 HERC2 MAPRE2 RPL19 | 4.08e-10 | 1353 | 103 | 21 | 29467282 |
| Pubmed | CUL4A CUL3 HINT1 POLR1A GATAD2A SMCHD1 MATR3 CHD1 SMARCAD1 PGD CSDE1 MFAP1 GTF2I SND1 TAF1 MED26 VBP1 ILKAP | 1.06e-09 | 1014 | 103 | 18 | 32416067 | |
| Pubmed | C11orf98 GATAD2A ANK2 RRP1B ACLY SMCHD1 MATR3 TRPM2 XPC CSDE1 MRM3 TGM2 MFAP1 GTF2I FARP1 PINX1 NKTR HERC2 CRBN | 1.94e-08 | 1371 | 103 | 19 | 36244648 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 18403125 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 2.52e-08 | 3 | 103 | 3 | 9204703 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 7876312 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 2.52e-08 | 3 | 103 | 3 | 12213830 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 9242641 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 2.52e-08 | 3 | 103 | 3 | 10788707 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 2.52e-08 | 3 | 103 | 3 | 7621815 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 18643873 | ||
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 11159936 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 2.52e-08 | 3 | 103 | 3 | 10473538 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 2.52e-08 | 3 | 103 | 3 | 4600883 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 7635066 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CUL3 POLR1A GATAD2A MYO5A RRP1B SMCHD1 MATR3 POLRMT CSDE1 MRM3 SND1 PINX1 HERC2 RPL19 | 5.66e-08 | 759 | 103 | 14 | 35915203 |
| Pubmed | POLR1A MYO5A RRP1B ACLY SMCHD1 POLRMT CHD1 CSDE1 GTF2I SND1 HERC2 RAI1 RPL19 | 7.30e-08 | 653 | 103 | 13 | 22586326 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 7.50e-08 | 182 | 103 | 8 | 31067453 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 18206662 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 1.01e-07 | 4 | 103 | 3 | 23413940 | |
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 9384575 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 9607712 | ||
| Pubmed | 1.01e-07 | 4 | 103 | 3 | 23482488 | ||
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 2.51e-07 | 5 | 103 | 3 | 19011160 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | GATAD2A RRP1B SMCHD1 CHD1 XPC SMARCAD1 GTF2I PINX1 TAF1 HERC2 RAI1 ILKAP | 2.63e-07 | 608 | 103 | 12 | 36089195 |
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 5.01e-07 | 6 | 103 | 3 | 26025922 | |
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 5.01e-07 | 6 | 103 | 3 | 14592808 | |
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 5.01e-07 | 6 | 103 | 3 | 25966694 | |
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 19009018 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 5.01e-07 | 6 | 103 | 3 | 16844763 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | AMD1 GATAD2A RRP1B SMCHD1 MATR3 CHD1 GTF2I CBX6 TAF1 HERC2 MED26 | 5.54e-07 | 533 | 103 | 11 | 30554943 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | HINT1 ANK2 ACLY SMCHD1 MATR3 CHD1 CSDE1 GTF2I SND1 PKN2 MAPRE2 VBP1 ILKAP RPL19 | 6.92e-07 | 934 | 103 | 14 | 33916271 |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 11860456 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 20962236 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.40e-06 | 8 | 103 | 3 | 19033399 | |
| Pubmed | 1.40e-06 | 8 | 103 | 3 | 11784029 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CUL4A CUL3 USP30 POLR1A USP46 PGD MRM3 GTF2I SND1 PKN2 HERC2 CRBN VBP1 MPP7 | 1.64e-06 | 1005 | 103 | 14 | 19615732 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | CUL4A POLR1A GATAD2A RRP1B ACLY SMCHD1 MATR3 CHD1 CSDE1 TGM2 MFAP1 GTF2I SND1 NKTR MAPRE2 RPL19 | 1.67e-06 | 1318 | 103 | 16 | 30463901 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CUL4A AMD1 DYM POLR1A MYO5A ARHGAP10 MAN1C1 TRPM2 OBSCN FGFRL1 CSDE1 GTF2I GALNT11 FARP1 KAT6B STX17 RAI1 | 1.75e-06 | 1489 | 103 | 17 | 28611215 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.57e-06 | 203 | 103 | 7 | 22083510 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.76e-06 | 394 | 103 | 9 | 27248496 | |
| Pubmed | GATAD2A MYO5A ARHGAP10 ACLY ARHGEF12 CHD1 PLEKHG5 CSDE1 MFAP1 FARP1 PINX1 NKTR MAPRE2 | 3.25e-06 | 916 | 103 | 13 | 32203420 | |
| Pubmed | POLR1A MYO5A RRP1B ACLY SMCHD1 MATR3 MRM3 TGM2 MFAP1 SND1 FARP1 | 4.35e-06 | 660 | 103 | 11 | 32780723 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CUL4A GATAD2A RRP1B SMCHD1 MATR3 NME2P1 CHD1 MFAP1 GTF2I PINX1 TAF1 RAI1 ILKAP | 5.04e-06 | 954 | 103 | 13 | 36373674 |
| Pubmed | 5.44e-06 | 12 | 103 | 3 | 19095005 | ||
| Pubmed | C11orf98 POLR1A GATAD2A RRP1B MATR3 POLRMT CHD1 XPC MFAP1 GTF2I FARP1 RPL19 | 8.11e-06 | 847 | 103 | 12 | 35850772 | |
| Pubmed | C11orf98 USP30 POLR1A MYO5A RRP1B ARHGAP10 POLRMT ARHGEF12 CHD1 XPC CSDE1 MRM3 SND1 FARP1 HERC2 MPP7 | 8.38e-06 | 1497 | 103 | 16 | 31527615 | |
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 8.69e-06 | 2 | 103 | 2 | 21531043 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 16678258 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 12565913 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 9489997 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17259277 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 9192302 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 8.69e-06 | 2 | 103 | 2 | 12640042 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 8.69e-06 | 2 | 103 | 2 | 14722100 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 27134178 | ||
| Pubmed | Structural and functional interactions within ryanodine receptor. | 8.69e-06 | 2 | 103 | 2 | 26009179 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 7556644 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 32899693 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 14592949 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 8898078 | ||
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 8.69e-06 | 2 | 103 | 2 | 15894801 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 30542613 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 14550562 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 8.69e-06 | 2 | 103 | 2 | 11673493 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 11673462 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 9799464 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 9817784 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 8.69e-06 | 2 | 103 | 2 | 25370123 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 14985349 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 8.69e-06 | 2 | 103 | 2 | 15033925 | |
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 8.69e-06 | 2 | 103 | 2 | 18618700 | |
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 8.69e-06 | 2 | 103 | 2 | 17118445 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 8.69e-06 | 2 | 103 | 2 | 11500519 | |
| Pubmed | 1.41e-05 | 483 | 103 | 9 | 36912080 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CUL4A GATAD2A RRP1B ACLY SMCHD1 MATR3 NUBP1 CHD1 SMARCAD1 CSDE1 MRM3 GTF2I SND1 PKN2 RPL19 | 1.82e-05 | 1415 | 103 | 15 | 28515276 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CUL3 GATAD2A MYO5A RRP1B ACLY SMCHD1 MATR3 POLRMT CSDE1 TGM2 MFAP1 GTF2I SND1 RPL19 | 2.07e-05 | 1257 | 103 | 14 | 36526897 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.23e-05 | 283 | 103 | 7 | 30585729 | |
| Pubmed | 2.50e-05 | 653 | 103 | 10 | 33742100 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 11171121 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 18313230 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 29018037 | ||
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 2.60e-05 | 3 | 103 | 2 | 29730765 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 12527750 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 24123915 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 16527807 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 19553612 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 23278119 | ||
| Pubmed | Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons. | 2.60e-05 | 3 | 103 | 2 | 23454728 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 26462735 | ||
| Interaction | SIRT7 interactions | CUL4A POLR1A MYO5A RRP1B ACLY SMCHD1 POLRMT CHD1 CSDE1 KAT2B GTF2I SND1 HERC2 RAI1 RPL19 | 4.93e-06 | 744 | 102 | 15 | int:SIRT7 |
| Interaction | H3-3A interactions | CUL3 GATAD2A RRP1B SMCHD1 CHD1 XPC SMARCAD1 KAT2B GTF2I CBX6 PINX1 TAF1 HERC2 RAI1 ILKAP | 5.35e-06 | 749 | 102 | 15 | int:H3-3A |
| Interaction | H3C1 interactions | CUL4A CENPW GATAD2A ANK2 RRP1B ARHGAP10 SMCHD1 CHD1 XPC KAT2B CBX6 PINX1 TAF1 KAT6B MAPRE2 RPL19 | 1.15e-05 | 901 | 102 | 16 | int:H3C1 |
| Interaction | ZNF330 interactions | CUL3 GATAD2A RRP1B SMCHD1 CHD1 XPC SMARCAD1 MFAP1 PINX1 TAF1 RAI1 | 1.61e-05 | 446 | 102 | 11 | int:ZNF330 |
| Interaction | XRCC6 interactions | CUL4A CUL3 GATAD2A RRP1B SMCHD1 MATR3 XPC SMARCAD1 CSDE1 MFAP1 KAT2B GTF2I TAF1 VBP1 ILKAP RPL19 | 1.65e-05 | 928 | 102 | 16 | int:XRCC6 |
| Interaction | CENPA interactions | 2.15e-05 | 377 | 102 | 10 | int:CENPA | |
| Interaction | CBX3 interactions | CUL4A CUL3 ACLY SMCHD1 CHD1 XPC SMARCAD1 PGD MFAP1 GTF2I CBX6 PINX1 ILKAP | 2.28e-05 | 646 | 102 | 13 | int:CBX3 |
| Interaction | PARP1 interactions | CUL4A CUL3 HINT1 POLR1A GATAD2A RRP1B SMCHD1 CHD1 XPC SMARCAD1 PGD MFAP1 KAT2B SND1 PINX1 PKN2 RAI1 ILKAP RPL19 | 2.95e-05 | 1316 | 102 | 19 | int:PARP1 |
| Interaction | NAA40 interactions | CUL3 HINT1 ANK2 ACLY SMCHD1 MATR3 CHD1 XPC CSDE1 GTF2I SND1 PKN2 MAPRE2 VBP1 ILKAP RPL19 | 3.13e-05 | 978 | 102 | 16 | int:NAA40 |
| Interaction | HECTD1 interactions | EPHB2 CUL3 POLR1A GATAD2A MYO5A RRP1B SMCHD1 MATR3 POLRMT CSDE1 MRM3 SND1 PINX1 TAF1 HERC2 RPL19 | 3.37e-05 | 984 | 102 | 16 | int:HECTD1 |
| Interaction | H2BC8 interactions | CUL4A CUL3 GATAD2A SMCHD1 CHD1 XPC SMARCAD1 TGM2 GTF2I PINX1 RAI1 ILKAP | 3.45e-05 | 576 | 102 | 12 | int:H2BC8 |
| Interaction | POLR1G interactions | POLR1A GATAD2A RRP1B SMCHD1 CHD1 XPC SMARCAD1 MFAP1 PINX1 TAF1 RAI1 | 3.74e-05 | 489 | 102 | 11 | int:POLR1G |
| Interaction | H2BC21 interactions | CUL4A CUL3 GATAD2A SMCHD1 OBSCN XPC USP46 TGM2 KAT2B CBX6 KAT6B RAI1 RPL19 | 4.92e-05 | 696 | 102 | 13 | int:H2BC21 |
| Interaction | ZNF816 interactions | 6.72e-05 | 16 | 102 | 3 | int:ZNF816 | |
| Interaction | QPCT interactions | 7.19e-05 | 44 | 102 | 4 | int:QPCT | |
| Interaction | ANK3 interactions | 7.34e-05 | 201 | 102 | 7 | int:ANK3 | |
| Interaction | NUP43 interactions | CUL4A GATAD2A RRP1B CHD1 XPC SMARCAD1 RYR2 MFAP1 GTF2I SND1 NKTR VBP1 | 7.55e-05 | 625 | 102 | 12 | int:NUP43 |
| Interaction | TMEM132C interactions | 7.58e-05 | 3 | 102 | 2 | int:TMEM132C | |
| Interaction | PPP1R13L interactions | 8.45e-05 | 88 | 102 | 5 | int:PPP1R13L | |
| Interaction | HDLBP interactions | C11orf98 GATAD2A SMCHD1 MATR3 TRPM2 XPC CSDE1 MRM3 TGM2 GTF2I FARP1 HERC2 CRBN RPL19 | 1.02e-04 | 855 | 102 | 14 | int:HDLBP |
| Interaction | ANK2 interactions | 1.41e-04 | 98 | 102 | 5 | int:ANK2 | |
| Interaction | KPNA4 interactions | 1.48e-04 | 225 | 102 | 7 | int:KPNA4 | |
| Interaction | CYFIP1 interactions | 1.54e-04 | 303 | 102 | 8 | int:CYFIP1 | |
| Interaction | MYCN interactions | CUL3 C11orf98 HINT1 POLR1A RRP1B ACLY SMCHD1 MATR3 ADCK2 CSDE1 MRM3 MFAP1 KAT2B GTF2I FARP1 PINX1 RAI1 RPL19 | 1.68e-04 | 1373 | 102 | 18 | int:MYCN |
| Interaction | GAR1 interactions | 1.79e-04 | 232 | 102 | 7 | int:GAR1 | |
| Interaction | ZNF829 interactions | 1.81e-04 | 22 | 102 | 3 | int:ZNF829 | |
| Interaction | MEN1 interactions | C11orf98 GATAD2A RRP1B SMCHD1 MATR3 POLRMT CHD1 XPC SMARCAD1 MFAP1 GTF2I FARP1 TAF1 KAT6B RPL19 | 2.04e-04 | 1029 | 102 | 15 | int:MEN1 |
| Interaction | H3C3 interactions | GATAD2A RRP1B SMCHD1 CHD1 XPC SMARCAD1 GTF2I PINX1 TAF1 RAI1 | 2.06e-04 | 495 | 102 | 10 | int:H3C3 |
| Interaction | TAF4B interactions | 2.07e-04 | 23 | 102 | 3 | int:TAF4B | |
| Interaction | UFL1 interactions | C11orf98 RRP1B ACLY SMCHD1 MATR3 POLRMT CSDE1 MRM3 MFAP1 GTF2I SND1 CCR1 PACC1 ILKAP RPL19 | 2.08e-04 | 1031 | 102 | 15 | int:UFL1 |
| Interaction | SRGAP3 interactions | 2.27e-04 | 59 | 102 | 4 | int:SRGAP3 | |
| Interaction | OTUD1 interactions | 2.28e-04 | 170 | 102 | 6 | int:OTUD1 | |
| Interaction | SMC3 interactions | 2.28e-04 | 408 | 102 | 9 | int:SMC3 | |
| Interaction | TPRG1 interactions | 2.36e-04 | 24 | 102 | 3 | int:TPRG1 | |
| Interaction | RAPGEF5 interactions | 2.43e-04 | 60 | 102 | 4 | int:RAPGEF5 | |
| Interaction | HP interactions | 2.52e-04 | 111 | 102 | 5 | int:HP | |
| Cytoband | 12q24.11 | 5.70e-05 | 33 | 103 | 3 | 12q24.11 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 4.23e-08 | 3 | 64 | 3 | 287 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.78e-05 | 17 | 64 | 3 | 486 | |
| GeneFamily | Cullins | 3.41e-04 | 8 | 64 | 2 | 1032 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.09e-03 | 14 | 64 | 2 | 1095 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.65e-03 | 66 | 64 | 3 | 722 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.87e-03 | 181 | 64 | 4 | 694 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | CUL4A AMD1 ATP7B ACLY MATR3 POLRMT CASP10 XPC PGD CSDE1 TGM2 MFAP1 GTF2I PIK3CB EBAG9 MAPRE2 CRBN VBP1 | 8.05e-06 | 1399 | 103 | 18 | M535 |
| Coexpression | LEE_BMP2_TARGETS_DN | EPHB2 CUL3 AMD1 C11orf98 CENPW POLR1A RRP1B SMCHD1 POLRMT CHD1 USP46 PGD MRM3 PINX1 | 1.51e-05 | 922 | 103 | 14 | MM1068 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-10 | 184 | 102 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-10 | 184 | 102 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-10 | 184 | 102 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.11e-08 | 185 | 102 | 8 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.53e-07 | 187 | 102 | 7 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.36e-07 | 195 | 102 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.66e-06 | 170 | 102 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.89e-06 | 189 | 102 | 6 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.89e-06 | 189 | 102 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-06 | 189 | 102 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 5.04e-06 | 190 | 102 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.51e-06 | 193 | 102 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.68e-06 | 194 | 102 | 6 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.38e-06 | 198 | 102 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.76e-06 | 200 | 102 | 6 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.76e-06 | 200 | 102 | 6 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.76e-06 | 200 | 102 | 6 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.76e-06 | 200 | 102 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.76e-06 | 200 | 102 | 6 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-neutrophil-neutrophil|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.72e-05 | 153 | 102 | 5 | ce6e462ce4dbaf9d265f1f9e2f791efbba8c1dd0 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-neutrophil|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.72e-05 | 153 | 102 | 5 | 9dba38574908f31a1194b8a339868f5e4be1be71 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 156 | 102 | 5 | f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 156 | 102 | 5 | da4f35353a84d919e683554932f110e29568df33 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 156 | 102 | 5 | f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 157 | 102 | 5 | 320d5ac063fd90e26f537475c328b3ae73974bc1 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 157 | 102 | 5 | e4b17c267b754c5af95cdf17f629354d1a8a8ad7 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 158 | 102 | 5 | 0ed844ab625351a46b74edddf082279ed1bae5c6 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 158 | 102 | 5 | b3a810314e253b4fd0f578e759c36fdd21722934 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-05 | 162 | 102 | 5 | ad974426039f4952c59d27167eac24dc6ce63f5e | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-neutrophil-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-05 | 162 | 102 | 5 | 4e7e565091bce227d794a36af2e5dfc4a791efad | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 164 | 102 | 5 | 0e424a69999eee13d27c4ff4f4ba3df64d3c2bda | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.79e-05 | 164 | 102 | 5 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 164 | 102 | 5 | fe9ecdd7a6cbaf910f42654eba75f79bea740a00 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD141+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.02e-05 | 166 | 102 | 5 | 9f14e3ef19d5903278c040be1c477501237173fa | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.25e-05 | 168 | 102 | 5 | 937332580a522826b820e0b09080013f19f58479 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-neutrophil-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.25e-05 | 168 | 102 | 5 | b0376e3687fa85f091654196403eecedc219d0cd | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 169 | 102 | 5 | a5964aef04093b460bbe29d5e2e7389f8fd2d46f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-05 | 169 | 102 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 169 | 102 | 5 | e0076aa61b4ef3f836f5750005d0469d3982eb6d | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 169 | 102 | 5 | 2341eddfedaad8cee779c37bb87f7def058588ca | |
| ToppCell | facs-Marrow-Granulocytes-18m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 169 | 102 | 5 | 94871936ccfc73b56d425373b989b87c059d4493 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-05 | 169 | 102 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 169 | 102 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 172 | 102 | 5 | a5344760b10ecdc0101f78b93b8fc0f8107068c5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-05 | 173 | 102 | 5 | ab6d3507301038f944ad59ccd848b5e6eeb76d04 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 5.30e-05 | 176 | 102 | 5 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.30e-05 | 176 | 102 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-05 | 176 | 102 | 5 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.90e-05 | 180 | 102 | 5 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.06e-05 | 181 | 102 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.22e-05 | 182 | 102 | 5 | d486b0213bd3cf20965cb4e38e95981c4aaff259 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.22e-05 | 182 | 102 | 5 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.38e-05 | 183 | 102 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.38e-05 | 183 | 102 | 5 | a253ad65673fce6cb453e709cb235ce7cbfa18b7 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.38e-05 | 183 | 102 | 5 | ddc45fb591ba0ce3fa05c08051d58286a89ef835 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 184 | 102 | 5 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 184 | 102 | 5 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 184 | 102 | 5 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.55e-05 | 184 | 102 | 5 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 6.72e-05 | 185 | 102 | 5 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.72e-05 | 185 | 102 | 5 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.72e-05 | 185 | 102 | 5 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.72e-05 | 185 | 102 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.72e-05 | 185 | 102 | 5 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.89e-05 | 186 | 102 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.07e-05 | 187 | 102 | 5 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.07e-05 | 187 | 102 | 5 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-05 | 187 | 102 | 5 | 83582c499cda6306fe5f66f2ac97e27ff420e228 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 7.25e-05 | 188 | 102 | 5 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 7.25e-05 | 188 | 102 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 7.25e-05 | 188 | 102 | 5 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.25e-05 | 188 | 102 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.25e-05 | 188 | 102 | 5 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.25e-05 | 188 | 102 | 5 | 5ba5cbb403518026e9040379fb5d99339ea977d8 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.43e-05 | 189 | 102 | 5 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.43e-05 | 189 | 102 | 5 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.43e-05 | 189 | 102 | 5 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 7.43e-05 | 189 | 102 | 5 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 7.43e-05 | 189 | 102 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 7.43e-05 | 189 | 102 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.43e-05 | 189 | 102 | 5 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 7.43e-05 | 189 | 102 | 5 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.62e-05 | 190 | 102 | 5 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.62e-05 | 190 | 102 | 5 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.62e-05 | 190 | 102 | 5 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.62e-05 | 190 | 102 | 5 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 7.62e-05 | 190 | 102 | 5 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.62e-05 | 190 | 102 | 5 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.62e-05 | 190 | 102 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 7.62e-05 | 190 | 102 | 5 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.81e-05 | 191 | 102 | 5 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.81e-05 | 191 | 102 | 5 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 7.81e-05 | 191 | 102 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.81e-05 | 191 | 102 | 5 | 24d75b7e1d6fb9d24aa7844f584ee888a449841f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.81e-05 | 191 | 102 | 5 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.81e-05 | 191 | 102 | 5 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.81e-05 | 191 | 102 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.00e-05 | 192 | 102 | 5 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|normal_Lung / Location, Cell class and cell subclass | 8.00e-05 | 192 | 102 | 5 | 097a13121820ab4e5cd2365600efccf5ea4ce8c3 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 8.00e-05 | 192 | 102 | 5 | eb4909574fb5fc91399463523e2737095773200a | |
| Drug | cis-diammineplatinum(II | 8.47e-08 | 3 | 101 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 8.47e-08 | 3 | 101 | 3 | CID002750949 | |
| Drug | 8N3-cADPR | 8.47e-08 | 3 | 101 | 3 | CID000127713 | |
| Drug | aminodantrolene | 8.47e-08 | 3 | 101 | 3 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 8.47e-08 | 3 | 101 | 3 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 8.47e-08 | 3 | 101 | 3 | CID005748312 | |
| Drug | PCB74 | 3.38e-07 | 4 | 101 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 3.38e-07 | 4 | 101 | 3 | CID006444275 | |
| Drug | SC 38249 | 3.38e-07 | 4 | 101 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 3.38e-07 | 4 | 101 | 3 | CID000035682 | |
| Drug | mag-fura-2 | 6.05e-07 | 37 | 101 | 5 | CID000123839 | |
| Drug | AC1L380G | 1.34e-06 | 19 | 101 | 4 | CID000084698 | |
| Drug | chloro-m-cresol | 1.68e-06 | 6 | 101 | 3 | CID000012008 | |
| Drug | MBED | 1.68e-06 | 6 | 101 | 3 | CID000129958 | |
| Drug | AC1O528X | 1.68e-06 | 6 | 101 | 3 | CID006475857 | |
| Drug | NSC114784 | 1.68e-06 | 6 | 101 | 3 | CID000419425 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 2.93e-06 | 7 | 101 | 3 | CID009547999 | |
| Drug | Azumoleno | 2.93e-06 | 7 | 101 | 3 | CID000056259 | |
| Drug | mag-indo-1 | 2.93e-06 | 7 | 101 | 3 | CID000131881 | |
| Drug | Br2BAPTA | 2.93e-06 | 7 | 101 | 3 | CID003081001 | |
| Drug | lomofungin | 4.30e-06 | 25 | 101 | 4 | CID005351222 | |
| Drug | strontium chromate | 5.27e-06 | 99 | 101 | 6 | CID000024599 | |
| Drug | isocitrate | 6.21e-06 | 156 | 101 | 7 | CID000001198 | |
| Drug | LOPAC | 9.15e-06 | 30 | 101 | 4 | CID000062696 | |
| Drug | AC1N38XE | 9.94e-06 | 10 | 101 | 3 | CID004060965 | |
| Drug | PCB 95 | 9.94e-06 | 10 | 101 | 3 | CID000038012 | |
| Drug | M-HN | 1.05e-05 | 31 | 101 | 4 | CID000015450 | |
| Drug | PCB 66 | 1.36e-05 | 11 | 101 | 3 | CID000036185 | |
| Drug | R 478 | 1.36e-05 | 11 | 101 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 1.36e-05 | 11 | 101 | 3 | CID003081323 | |
| Drug | Ryanodine | 1.81e-05 | 12 | 101 | 3 | ctd:D012433 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 1.95e-05 | 2 | 101 | 2 | ctd:C005147 | |
| Drug | NSC299933 | 2.35e-05 | 13 | 101 | 3 | CID000431902 | |
| Drug | NAADP | 2.66e-05 | 39 | 101 | 4 | CID000123952 | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.82e-05 | 197 | 101 | 7 | 6619_UP | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.82e-05 | 197 | 101 | 7 | 3635_DN | |
| Drug | arabinosyladenine | GABRR2 MGAM HINT1 ATP7B GANC POLRMT PGD RYR1 RYR2 RYR3 GUCY2C PIK3CB PKN2 | 3.23e-05 | 762 | 101 | 13 | CID000000191 |
| Drug | FPL 64176 | 3.71e-05 | 15 | 101 | 3 | CID000003423 | |
| Drug | Gvapspat amide | 3.71e-05 | 15 | 101 | 3 | CID000125015 | |
| Drug | AC1N9ZZC | 5.40e-05 | 149 | 101 | 6 | CID004369374 | |
| Drug | kazinol B | 5.51e-05 | 17 | 101 | 3 | CID000480869 | |
| Drug | AC1NUZ8M | 5.63e-05 | 92 | 101 | 5 | CID000073211 | |
| Drug | MW 1 | 5.81e-05 | 151 | 101 | 6 | CID000073965 | |
| Drug | 7-deoxy-6-epi-castanospermine | 5.83e-05 | 3 | 101 | 2 | CID000125391 | |
| Drug | AC1NUR2V | 5.83e-05 | 3 | 101 | 2 | CID005489114 | |
| Drug | callyspongynic acid | 5.83e-05 | 3 | 101 | 2 | CID000636783 | |
| Drug | IPG7F | 5.83e-05 | 3 | 101 | 2 | CID003083273 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 5.83e-05 | 3 | 101 | 2 | CID000080262 | |
| Drug | Pradimicin Q | 5.83e-05 | 3 | 101 | 2 | CID000073572 | |
| Drug | flubendiamide | 5.83e-05 | 3 | 101 | 2 | CID011193251 | |
| Drug | 3-nitro-4-(6-aminohexylamido)phenylboronic acid | 5.83e-05 | 3 | 101 | 2 | CID000133488 | |
| Drug | methylcoumarin | 6.59e-05 | 18 | 101 | 3 | CID000007092 | |
| Drug | etridiazole | 7.18e-05 | 50 | 101 | 4 | CID000017432 | |
| Drug | AC1MW7VF | 7.80e-05 | 19 | 101 | 3 | CID000414699 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 8.17e-05 | 233 | 101 | 7 | CID000005114 | |
| Drug | silver hydride | 9.14e-05 | 20 | 101 | 3 | CID000139654 | |
| Drug | indo-1/AM | 1.06e-04 | 21 | 101 | 3 | CID000123918 | |
| Drug | strictosidine | 1.06e-04 | 21 | 101 | 3 | CID000161336 | |
| Drug | A-30 | 1.16e-04 | 4 | 101 | 2 | CID003028528 | |
| Drug | myrciaphenone B | 1.16e-04 | 4 | 101 | 2 | CID000183139 | |
| Drug | titanium silicate | 1.16e-04 | 4 | 101 | 2 | CID011600682 | |
| Drug | NSC277293 | 1.16e-04 | 4 | 101 | 2 | CID000321973 | |
| Drug | gamma-glutamyl-2-naphthylamide | 1.16e-04 | 4 | 101 | 2 | CID000164706 | |
| Drug | atalaphyllidine | 1.16e-04 | 4 | 101 | 2 | CID005479542 | |
| Drug | glycovir | 1.16e-04 | 4 | 101 | 2 | CID000060807 | |
| Drug | thiochroman-4-one | 1.16e-04 | 4 | 101 | 2 | CID000019048 | |
| Drug | 2-deoxymaltose | 1.16e-04 | 4 | 101 | 2 | CID003081508 | |
| Drug | AC1L3RZ0 | 1.16e-04 | 4 | 101 | 2 | CID000145814 | |
| Drug | Bastadin 10 | 1.16e-04 | 4 | 101 | 2 | CID009589366 | |
| Drug | thiopental | 1.43e-04 | 112 | 101 | 5 | CID003000715 | |
| Drug | Puromycin dihydrochloride [58-58-2]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.53e-04 | 180 | 101 | 6 | 5310_DN | |
| Drug | IAA-94 | 1.57e-04 | 61 | 101 | 4 | CID000003667 | |
| Drug | AC1NBU2S | 1.76e-04 | 117 | 101 | 5 | CID004473765 | |
| Drug | T0702 | 1.82e-04 | 25 | 101 | 3 | CID000005908 | |
| Drug | tetrachlorophthalimide | 1.93e-04 | 5 | 101 | 2 | CID000074077 | |
| Drug | D-gluco-octenitol | 1.93e-04 | 5 | 101 | 2 | CID006438548 | |
| Drug | A 68930 | 1.93e-04 | 5 | 101 | 2 | ctd:C065380 | |
| Drug | (-)-Lentiginosine | 1.93e-04 | 5 | 101 | 2 | CID000130407 | |
| Drug | beta-D-glucopyranosyl azide | 1.93e-04 | 5 | 101 | 2 | CID000152302 | |
| Drug | pulmatin | 1.93e-04 | 5 | 101 | 2 | CID000442731 | |
| Drug | Ro 22-0654 | 1.93e-04 | 5 | 101 | 2 | CID000133753 | |
| Drug | gallopamil | 2.26e-04 | 67 | 101 | 4 | CID000001234 | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; HL60; HG-U133A | 2.29e-04 | 194 | 101 | 6 | 1404_UP | |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; HL60; HG-U133A | 2.36e-04 | 195 | 101 | 6 | 1783_DN | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; PC3; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 4070_UP | |
| Drug | Niclosamide [50-65-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 1498_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 4298_UP | |
| Drug | Benzocaine [94-09-7]; Down 200; 24.2uM; PC3; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 4224_DN | |
| Drug | strontium | 2.39e-04 | 68 | 101 | 4 | CID000104798 | |
| Drug | Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.42e-04 | 196 | 101 | 6 | 5461_DN | |
| Drug | MK-886; Down 200; 1uM; MCF7; HG-U133A | 2.49e-04 | 197 | 101 | 6 | 601_DN | |
| Drug | Mifepristone [84371-65-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 5827_UP | |
| Drug | Urosiol [128-13-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 7243_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; HL60; HG-U133A | 2.56e-04 | 198 | 101 | 6 | 1985_UP | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; HL60; HG-U133A | 2.63e-04 | 199 | 101 | 6 | 1970_UP | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; HL60; HG-U133A | 2.63e-04 | 199 | 101 | 6 | 1987_UP | |
| Drug | Thioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; PC3; HT_HG-U133A | 2.63e-04 | 199 | 101 | 6 | 4085_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; HL60; HG-U133A | 2.63e-04 | 199 | 101 | 6 | 1383_UP | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; HL60; HG-U133A | 2.70e-04 | 200 | 101 | 6 | 2008_UP | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.70e-04 | 200 | 101 | 6 | 3935_UP | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 3.78e-08 | 3 | 100 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 3.78e-08 | 3 | 100 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | mastiha supplement exposure measurement, interleukin-6 measurement | 6.79e-05 | 4 | 100 | 2 | EFO_0004810, EFO_0600067 | |
| Disease | age at diagnosis, coronary atherosclerosis measurement | 1.69e-04 | 6 | 100 | 2 | EFO_0004918, EFO_0007938 | |
| Disease | melanoma | 2.05e-04 | 248 | 100 | 6 | C0025202 | |
| Disease | heart disease (implicated_via_orthology) | 2.92e-04 | 38 | 100 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | triacylglycerol 58:6 measurement | 3.14e-04 | 8 | 100 | 2 | EFO_0010440 | |
| Disease | testosterone measurement | CENPW POLR1A ZAN ANK2 MYO5A ARHGAP10 TRPM2 FGFRL1 KAT2B GTF2I PINX1 HHIPL1 RAI1 | 3.73e-04 | 1275 | 100 | 13 | EFO_0004908 |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 5.03e-04 | 10 | 100 | 2 | C1631597 | |
| Disease | Metastatic melanoma | 8.26e-04 | 54 | 100 | 3 | C0278883 | |
| Disease | language measurement | 1.14e-03 | 134 | 100 | 4 | EFO_0007797 | |
| Disease | cortical thickness | CENPW GATAD2A ARHGEF12 FGFRL1 SMARCAD1 TENM2 STPG2 SND1 EBAG9 MAPRE2 EPHA7 | 1.38e-03 | 1113 | 100 | 11 | EFO_0004840 |
| Disease | basophil percentage of leukocytes | 1.45e-03 | 243 | 100 | 5 | EFO_0007992 | |
| Disease | thyroxine measurement, triiodothyronine measurement | 1.50e-03 | 17 | 100 | 2 | EFO_0005130, EFO_0008392 | |
| Disease | Alzheimer disease, brain volume measurement | 1.50e-03 | 17 | 100 | 2 | EFO_0006930, MONDO_0004975 | |
| Disease | Liver diseases | 1.90e-03 | 72 | 100 | 3 | C0023895 | |
| Disease | Liver Dysfunction | 1.90e-03 | 72 | 100 | 3 | C0086565 | |
| Disease | asthma, response to diisocyanate | 1.98e-03 | 261 | 100 | 5 | EFO_0006995, MONDO_0004979 | |
| Disease | coronary artery disease | HINT1 ADAM19 CENPW RRP1B ARHGEF12 CYP46A1 FARP1 PKN2 HHIPL1 MAPRE2 RAI1 | 2.40e-03 | 1194 | 100 | 11 | EFO_0001645 |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 2.57e-03 | 80 | 100 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | 2.69e-03 | 702 | 100 | 8 | C0009402 | |
| Disease | Autism Spectrum Disorders | 3.05e-03 | 85 | 100 | 3 | C1510586 | |
| Disease | response to mTOR inhibitor | 3.24e-03 | 25 | 100 | 2 | EFO_0005417 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKKVLAPRVNLTFRK | 241 | Q6NS38 | |
| IPVDLKRKIARLGIN | 416 | Q7Z695 | |
| RQLLLRIQKFKGPDI | 1791 | Q96N23 | |
| TVRIINRKVKPREPK | 156 | O95503 | |
| QGKRKVINTPEILRK | 771 | Q9H013 | |
| IEGKVRKLQGVVRVK | 161 | P35670 | |
| KQIKRKAPRGFLKRV | 11 | Q5EE01 | |
| KVKVNLVYLERRPKV | 76 | Q8N4C9 | |
| KVKAIGRQRFKVLEL | 156 | Q96SW2 | |
| KKPRRIILLVKAGQA | 66 | P52209 | |
| DRRTGKPIAVKLVKI | 76 | O75534 | |
| DPNLVIRKRKVGVLL | 51 | Q9H257 | |
| VLKQRPRFVALKKQP | 456 | O14646 | |
| IRRIEKIRQKGFVQK | 266 | Q76M96 | |
| EHKRGRIGFLPKIKQ | 566 | Q9NZN5 | |
| KVLEVKKPPRFLQRN | 456 | Q7Z4T9 | |
| QKIVIKKREPLNFGI | 106 | O00559 | |
| PRKGRGLKLEAIVQK | 1321 | Q7Z5J4 | |
| LPRLVVKSLKEKGFV | 801 | P25092 | |
| PQSVAIKRKRPFVLK | 1116 | Q8WYB5 | |
| KEINFCRKVKLPIIG | 211 | P53384 | |
| KVRVEKEKGPILTQR | 2026 | Q01484 | |
| PVLKQVIKPRRKLAF | 496 | Q86YP4 | |
| TLIKPLEKFRKEQLG | 111 | A1A4S6 | |
| EPRLKPVFIRKKDRV | 196 | P55081 | |
| ERKELLPKKIEIGIR | 4581 | Q9NZR2 | |
| KYKKLVLRIPNRGID | 571 | P43243 | |
| LIQTKVPKVGRVERK | 486 | Q14439 | |
| FKLLRKSILQRGKPV | 191 | Q92831 | |
| SERRDILGIFPIKKK | 216 | Q5VWC8 | |
| VKIRSRLIPFVPKEK | 591 | Q96JK4 | |
| RKPQVVEGLRGKKIV | 3246 | O95714 | |
| LIKKNPFGIEIRRKS | 1086 | O43451 | |
| VLIKKNPFGIEIRRK | 1981 | O43451 | |
| KLPGKREIFVAIKTL | 641 | P29323 | |
| KRRLKGQIPEIKQTL | 71 | P61758 | |
| RFRVLPQGLKVKQVE | 76 | Q8N441 | |
| RRGKKKLQKPVEIAE | 296 | Q96BK5 | |
| PGKIKVIRNTKREGL | 211 | Q8NCW6 | |
| LIKRSKGKERPFVLT | 556 | Q8TET4 | |
| RLVKNREPLGATIKK | 141 | Q5T2T1 | |
| DTIFGKIIRKEIPAK | 16 | P49773 | |
| RLKLPGKRDVAVAIK | 651 | Q15375 | |
| AEAGVKPVRLKERKL | 411 | O95402 | |
| PGFILDQKVKIRRRI | 101 | Q96M63 | |
| KSALIVQGPREVKKR | 166 | Q9H813 | |
| LRVREAPVLFKKKLE | 1981 | Q5VST9 | |
| GVRVKEPVKELLRRK | 21 | Q16633 | |
| GKVLLILFPDRVKRN | 26 | P49895 | |
| IIKKEPGQKLLFRFL | 291 | Q9Y603 | |
| KFLPGKRKQLREVRE | 231 | Q9Y6A2 | |
| IIKQGVVALPKDRLK | 606 | Q7RTS9 | |
| GIIKILLRRPNEKKS | 221 | P32246 | |
| IVKQIRRPKHVVVKF | 101 | Q9Y4F1 | |
| KARFLPSPVVIKKRI | 731 | Q13618 | |
| KKLVIKNFRDRPRLP | 41 | Q13619 | |
| DLIRKVVEVFKPGKF | 266 | P17707 | |
| LIRKFPKGDVISVEK | 171 | Q9H0C8 | |
| VFIDSIPKKIRKQRL | 216 | Q8TC29 | |
| KRKPKVLGVVRILIA | 41 | Q96PG1 | |
| DKVIPVEKLVKGRFQ | 131 | Q15555 | |
| RNIRKVLRKIEKPFG | 351 | Q9NR34 | |
| TVVPKLLRNIEKYKR | 176 | Q92851 | |
| IRLKAPGVITRKVVK | 336 | Q9NYL5 | |
| KIIQVGNRIKFVIKR | 526 | P78347 | |
| GNRIKFVIKRPELLT | 531 | P78347 | |
| FGIPRLEKILRNKAK | 786 | P78347 | |
| KVPLVIFKREKELAR | 4666 | P21817 | |
| PLVIFKREKEVARKL | 4596 | Q92736 | |
| VNLTGLKKREPLRKR | 846 | O00411 | |
| LGLKQRRKQILFPEK | 616 | Q9H159 | |
| DVTKIRKGKPQQLLR | 46 | P28476 | |
| KRQKKGIPLIFEREE | 336 | Q7Z2Y5 | |
| NDGILRKELRKKLPV | 61 | Q9Y5Y5 | |
| GIRQILEKKEGLFRK | 416 | O95602 | |
| LKRKRKLGVVPVNGS | 521 | Q14684 | |
| FEKGKVPKIVNLREI | 381 | A6NHR9 | |
| AKQIIKPFILRRVKE | 711 | Q9H4L7 | |
| KPFILRRVKEEVLKQ | 716 | Q9H4L7 | |
| LFILRAKVKKGVNIL | 321 | Q8N3T6 | |
| GLRIEIKSKNKVRPG | 1261 | P30414 | |
| VKSRPFREKQGKILL | 111 | Q9HC36 | |
| LLRKFGVPEEEIKKL | 1006 | P21675 | |
| VGKIIKRFEQKGFRL | 6 | O60361 | |
| IRKLIKDGLIIRKPV | 41 | P84098 | |
| PAREFLRKKLIGKEV | 81 | Q7KZF4 | |
| EQIKGKVTIFGRKLR | 1826 | Q9NT68 | |
| PVIERRPKLQRQKKI | 481 | Q16513 | |
| KSKFGIKRERVPFIL | 946 | P42338 | |
| VVKPDQLIKRRGKLG | 56 | P53396 | |
| GKINRPRTELKKKLF | 6 | E9PRG8 | |
| IRILGEPKQKRKLVA | 591 | P21980 | |
| KKKSLGEVLLPVFER | 96 | O94827 | |
| PLVVFKREKEIARKL | 4501 | Q15413 | |
| PRLYEIIVLQEKKKR | 191 | Q8N412 | |
| EKVKLRRLEPAIQKF | 6 | P56962 | |
| QLFIKRVVLKTPAKR | 1091 | O94759 | |
| QDVLKKPIVGRKICI | 236 | Q9H777 | |
| RPLERQVKKGKLDTV | 66 | Q658L1 | |
| VIPPKKFISRLRKEN | 96 | P62068 | |
| ITERKKRRKGLVPGL | 56 | Q70CQ3 | |
| LKKARVVRLGEVPYK | 691 | Q01831 | |
| GQVPERLLKVVKRVL | 2561 | O15050 | |
| LFRKEKPPDQKLVVR | 16 | Q9Y493 | |
| RSLRGIVPNLAKKVK | 676 | Q8N8K9 | |
| IIRKFIKGFISRNKP | 756 | Q8N1T3 | |
| KLVKNLILELKPRGV | 1486 | Q9Y4I1 |